Related Experiment Videos
Colony-stimulating factors in acute leukemia: will we ever have an answer?
1Department of Pharmacy Practice and Pharmacy Administration, University of the Sciences in Philadelphia, 600 S. 43rd St., Philadelphia, PA 19104-4495, USA. r.finley@usip.edu
The Annals of Pharmacotherapy
|February 24, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Future directions in the treatment of non-small cell lung cancer.
Seminars in oncology·2000
Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998
Patient care issues: the management of paclitaxel-related toxicities.
The Annals of pharmacotherapy·1994
Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·1993
Drug interactions in the oncology patient.
Seminars in oncology nursing·1992
Doravirine/Islatravir: A 2-Drug Regimen for the Treatment of HIV-1 Infection.
The Annals of pharmacotherapy·2026
Obecabtagene Autoleucel in Relapsed/Refractory B-ALL: A Critical Review of Clinical Efficacy and Safety.
The Annals of pharmacotherapy·2026
Depemokimab-ulaa: A Long-Acting Interleukin-5 Inhibitor.
The Annals of pharmacotherapy·2026
Clinical Evaluation of Bysanti: A New Atypical Antipsychotic for Schizophrenia and Bipolar I Disorder.
The Annals of pharmacotherapy·2026
Association between hematuria remission at 6 months and subsequent kidney outcomes in IgA nephropathy.
Journal of nephrology·2026
Tgfbr3 is required for the long-term maintenance of self-renewal potential in murine hematopoietic stem cells.
Blood science (Baltimore, Md.)·2026